Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Medtronic's miniature leadless pacemaker, the Micra Transcatheter Pacing System (TPS), is expected to secure FDA approval during the company's 2017 fiscal year. That stretches from May 2016 through ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

Medtronic's Micra Transcatheter Pacing System (TPS) is a leadless pacemaker that is implanted into the heart using a transcatheter procedure. Micra TPS received CE Mark in April 2015 and is the ...

The work was also published in Circulation. The device is designed to surround a leadless pacemaker, such as the Medtronic Micra, which sits in the heart's right ventricle. The challenge with a ...

Medtronic plc’s MDT strength in the Cardiovascular business is poised to drive growth in the upcoming quarters. The company’s ...

Five years prior to that, Cortez was the first physician in the world to implant a Micra single-chamber leadless pacemaker through the internal jugular vein in a child.

Medtronic plc’s MDT strength in the ... The company’s next-generation Micra AV2and VR2 leadless pacemakers are particularly driving growth as they successfully enter new geographies and ...